Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Recent Patents on Inflammation & Allergy Drug Discovery|March 29, 2012
Adenotonsillar diseaseAndreas E Zautner
Berliner Und Munchener Tierarztliche Wochenschrift|April 17, 2015
Campylobacter jejuni: components for adherence to and invasion of eukaryotic cellsRaimond Lugert, Uwe Gross, Andreas E Zautner
Antibiotics (Basel, Switzerland)|July 9, 2020
Impact of Case Definitions on Efficacy Estimation in Clinical Trials-A Proof-of-Principle Based on Historical ExamplesAndreas Hahn, Hagen Frickmann, Andreas E Zautner
Biomed Research International|October 25, 2014
Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient managementHagen Frickmann, Wycliffe Omurwa Masanta, Andreas E Zautner
Animals : an Open Access Journal From MDPI|February 15, 2020
Application of Campylobacter jejuni Phages: Challenges and PerspectivesLeonid Ushanov, Besarion Lasareishvili, Irakli Janashia, et al.
European Journal of Microbiology & Immunology|June 22, 2019
Antibiotic Susceptibility Profiles of Campylobacter coli Isolated from Poultry Farms in Lagos Nigeria - A Pilot StudyOreva Ogbor, Abraham Ajayi, Andreas E Zautner, et al.
Journal of Virology|June 16, 2006
N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cellsAndreas E Zautner, Birgit Jahn, Elke Hammerschmidt, et al.
Archives of Orthopaedic and Trauma Surgery|June 30, 2009
Spondylodiscitis of the lumbar spine in a non-immunocompromised host caused by Yersinia enterocolitica O:9Martin Ellenrieder, Andreas E Zautner, Andreas Podbielski, et al.
Journal of Clinical Microbiology|September 19, 2014
Yeast on-target lysis (YOTL), a procedure for making auxiliary mass spectrum data sets for clinical routine identification of yeastsMareike Bernhard, Michael Weig, Andreas E Zautner, et al.
Pageof 7